Arvind Subramanian
Chief Executive Officer
Arvind Subramanian is the President & CEO of VC-backed HealthMyne, Inc., bringing 26 years of healthcare technology (diagnostic imaging and healthcare IT sectors) experience to this role. His career includes CEO/COO/VP/GM and other management roles in large and small companies, including GE (GE Medical Systems; GE Information Services), Wolters Kluwer (WK Health-Clinical Solutions), and a VC-backed technology startup, ProVation Medical, that completed a successful strategic exit sale in 2006. He received an “Outstanding Entrepreneur” award from NEA (New Enterprise Associates), a top-tier global venture capital firm, for his work in building and scaling ProVation Medical. Arvind received his BA & MBA degrees from Case Western Reserve University (Cleveland, OH).
Linda Peitzman, MD
Chief Medical Informatics Officer (CMIO)
Dr. Linda Peitzman brings over 25 years of experience in the areas of Healthcare IT applications software, informatics and clinical decision support offerings to HealthMyne. She has deep process expertise in EMR integration, quality improvement, codified medical terminologies, data integration and management, physician change management and many other areas of healthcare clinical workflow optimization. She is a Fellow of the American Academy of Family Physicians and a Diplomate of the American Board of Family Medicine. Linda also holds a Board Certification in Clinical Informatics and received her MD from the University of Minnesota.
Roger Chylla, PhD
Chief Technology Officer
Roger is an experienced technology entrepreneur who brings many years of successful commercial software design and development experience to HealthMyne’s team. Roger was a co-founder and CTO of Madison-based Ultravisual Medical Systems, prior to its merger with Emageon. At Ultravisual and later at Emageon, Roger was the senior engineering manager in charge of the medical imaging product, RadSuite, which by 2008 was installed at more than a hundred clinics nationwide. Roger was part of the executive team that led Emageon to a successful IPO in 2005 (NASDAQ: EMAG), generating over $500 M in cumulative revenues. The company reached a peak market capitalization of around $400 million prior to its sale to Amicas. Prior to forming UltraVisual, Roger was employed as senior software architect at ADAC Labs, where he served as design/development lead for new products. Roger has a Ph.D. in Biophysics from University of Illinois at Urbana Champaign.
Neal Miller, MBA
Vice President of Marketing
Neal has nearly 20 years of pharmaceutical and medical device marketing experience, including almost 14 years in radiation oncology. Before joining HealthMyne he was the Director of Marketing for Mobius Medical Systems, a startup firm that introduced a paradigm shift in patient plan and patient delivery QA to radiation therapy departments worldwide. Neal also held positions in marketing and product management at Standard Imaging and was an integral part of the marketing team at Bone Care International that launched Hectorol®, a vitamin D derivative used in the treatment of kidney disease.
Brian Bircher
Vice President of Service
Brian Bircher is passionate about leveraging technology to improve the healthcare experience for both patients and providers. His focus is to ensure customer installs go smoothly and that all ongoing support needs are met. Brian believes delivery of high quality results is driven by close collaboration between partners with rigorous attention to detail and process. Prior to joining HealthMyne, Brian worked at Epic for 11 years in a number of roles centered on enterprise wide implementations of industry-leading applications.
Colleen E. Donnelly, CPA
Director of Finance and HR
Colleen has been the Director of Finance and HR for the company since inception. Prior to HealthMyne, Inc., she worked for a variety of companies, both public and private, in various financial and general management roles. Over the course of her career which spans twenty-five years, she served in accounting, human resource and SAP project implementation capacities. She acquired her initial experience with Price Waterhouse leaving as an audit manager after serving six years. Colleen has a Bachelor of Business Administration from the University of Notre Dame. She holds a CPA and is a member of the AICPA and WICPA Societies.
Arvind Subramanian
Chief Executive Officer
Arvind Subramanian is the President & CEO of VC-backed HealthMyne, Inc., bringing 26 years of healthcare technology (diagnostic imaging and healthcare IT sectors) experience to this role. His career includes CEO/COO/VP/GM and other management roles in large and small companies, including GE (GE Medical Systems; GE Information Services), Wolters Kluwer (WK Health-Clinical Solutions), and a VC-backed technology startup, ProVation Medical, that completed a successful strategic exit sale in 2006. He received an “Outstanding Entrepreneur” award from NEA (New Enterprise Associates), a top-tier global venture capital firm, for his work in building and scaling ProVation Medical. Arvind received his BA & MBA degrees from Case Western Reserve University (Cleveland, OH).
T. “Rock” Mackie, PhD
Chairman
Rock is a Director of Medical Devices (part-time) at the Mortgridge Institute for Research in Madison and Emeritus Professor in the departments of Medical Physics, Human Oncology, and Engineering Physics at the UW-Madison. In 1997, Rock co-founded TomoTherapy Inc., which developed an innovative, integrated hardware/software system for accurate, image-guided radiation treatment delivery. TomoTherapy’s initial public offering in 2007 reached a peak market capitalization of over $1.2 B under Rock’s leadership as chairman of the board of directors. Prior to its sale to Accuray, TomoTherapy’s cumulative revenues exceeded $ 1 billion. In 1992, Rock co-founded Geometrics, a HCIT company which developed the PinnacleTM Radiation Treatment Planning (RTP) system, now marketed by Philips Medical Systems. From 1996 until 2012, Pinnacle generated over $350 M in revenues and achieved a 45+% global market share. Rock has a doctorate in Physics from the University of Alberta. He has more than 150 publications and over 30 inventions with issued US patents.
Praveen Sinha, PhD, MBA
Vice President of Business Development
Praveen is a seasoned technology entrepreneur with more than 15 years of experience in healthcare technology. In 2006, he co-founded NovaShield Inc., a developer of IT security products, and served as its CEO. At NovaShield, Praveen raised over $6.5 M in equity from angel investors and SBIR grants. In 2000, Praveen co-founded UltraVisual Medical Systems (UVMS), a leading developer of medical imaging information technology system, and served as its COO from inception. At UVMS, he was instrumental in raising more than $10 M in equity capital, and led the company’s growth and business strategy. UVMS merged with Emageon in 2003 and had a successful IPO in 2005. Praveen began his business career as product manager with ADAC Labs, a leader in nuclear medicine and radiation treatment planning systems. Prior to ADAC, Praveen was a N.I.H. fellow at Univ. of Wis. Hospitals and Clinics. Praveen has a Ph.D. in Physics and a M.S. in Computer Science from Washington State University. He also holds an M.B.A. with a concentration in finance and entrepreneurship from the University of Chicago.
Milton Silva-Craig, J.D., MBA
Full Bio Milton Silva-Craig, J.D., MBA
Mr. Silva-Craig currently serves as the CEO of Q-Centrix, LLC. He has more than 20 years of business leadership experience in the healthcare and information technology industries and has demonstrated success in leading and managing high-growth businesses. Prior to Q-Centrix, Silva-Craig served as president of TransUnion’s healthcare business unit.
There, he developed and executed a strategic business plan focused on growing and repositioning TransUnion in the healthcare marketplace. His work resulted in an eight-fold increase in growth of the business unit. At Emageon Inc. (NASDAQ: EMAG), Silva-Craig led the company’s strategic direction and operations. He grew revenues from several hundred thousand dollars to more than $100 million annually and eventually led Emageon through its initial public offering. He was also president and CEO of Technology Solutions Company (NASDAQ: TSCC) and held executive positions at General Electric Medical Systems. Silva-Craig earned a J.D. from the University of Wisconsin-School of Law in Madison and obtained his M.B.A. and B.A. from the University of Wisconsin – Madison.
Scott Button, CFA, MBA
Full Bio Scott Button, CFA, MBA
Scott is a Managing Director at Venture Investors, a leading provider of seed and early stage venture capital with over $250M in management. Scott joined the firm in 1996 and focuses on investment opportunities in medical devices, digital health, material sciences and information technology. He created the firm’s Venture Igniter program to encourage and support academic and student led start-ups.
Scott currently represents Venture Investors on the Board of Directors for HealthMyne, Silatronix, and NeuWave Medical. He serves on the Board of Advisors for the University of Wisconsin’s Chemistry Department, is a member of the Madison Development Corporation’s Debt Advisory Committee, is a MERLIN Mentor and a frequent guest lecturer at the UW Madison Business and Engineering schools. Prior to joining Venture Investors, Scott worked for McDonald’s Corporation and Rockwell Automation. He is a graduate of the University of Wisconsin-Madison (BS–Mechanical Engineering), The University of Chicago (MBA) and is a Chartered Financial Analyst (CFA).
Dan Malven, MBA
Full Bio Dan Malven, MBA
Dan has over two decades of operating and venture capital experience. Prior to 4490 Ventures, Dan was investing in early stage software companies at 1347 Ventures. Dan was also previously an executive at Walgreens and the co-founder of three software companies. Dan has a Master of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Sciences in Industrial Engineering from Purdue University.
Mark Gehring
Senior Technology Advisor & Co-Founder
Prior to joining HealthMyne, Mark was a co-founder and President of Propeller Health (formerly Asthmapolis), a respiratory disease management company that employs sensors to track adherence and measure patient response to treatment. Previously Mark was a co-founder and CEO of two medical imaging companies that are also relevant to HealthMyne. Geometrics developed the Pinnacle 3D radiation treatment planning system which has had dominant market share worldwide since the mid 90’s and is now sold by Philips Medical Systems. Pinnacle has been used to plan approximately 25% of the radiation treatments worldwide since 1996. UltraVisual developed a web-based, 3D-enabled PACS used by radiologists to diagnostically read images and by clinicians to view images at large hospitals and hospital networks. UltraVisual merged with another startup, Emageon, and reached over $100 million in sales, and executed a successful IPO on Nasdaq in 2005
Gary Wendt, MD, MBA
Full Bio Gary Wendt, MD, MBA
Dr. Wendt is a professor of Radiology at the University of Wisconsin-Madison and vice-chair of Informatics. The UW Health radiology network which he oversees is one of the largest in the world consisting of 70 radiologists, over 2000 physicians, and 700,000 exams managed per year.
Dr. Wendt is board-certified in diagnostic radiology and specializes in neuroradiology. He has served as an advisor to many HCIT companies including McKesson, Vital Images and UltraVisual. He is a renowned expert in the field of advancing medical imaging technology to improve imaging quality and patient outcome. Dr. Wendt received an M.D. from the Medical College of Wisconsin and an MBA from the University of Wisconsin-Madison. He has co-authored over 30 publications and has over 50 invited presentations.
Robert J. Gillies, PhD
Full Bio Robert J. Gillies, PhD
Dr. Gillies received his PhD in Zoology from UC Davis in 1979. After a post-doctoral appointment at Yale University (1979-1982), he has held faculty positions at Colorado State Univ. (1982-1988), the Univ. of Arizona (1988-2008) and the Moffitt Cancer Center (2008-pres), where he is chair of the Department of Cancer Imaging and Metabolism, vice-chair of Radiology and director of the Center of Excellence in Imaging and Technology.
He has published over 243 peer-reviewed articles in the use of imaging and spectroscopy to interrogate tumor physiology, and is currently PI or co-PI on eight NCI grants or sub-contracts focused on cancer imaging. He has a long-standing interest in detailed image analysis to better describe tumor physiology and, in 2009, he coined the term “Radiomics”. He has been a major contributor to this field ever since, primarily in improved diagnosis of lung and prostate cancer.
